185 related articles for article (PubMed ID: 36579732)
21. A Review of Current and Emerging Therapeutic Options for Hemophagocytic Lymphohistiocytosis.
Summerlin J; Wells DA; Anderson MK; Halford Z
Ann Pharmacother; 2023 Jul; 57(7):867-879. PubMed ID: 36349896
[TBL] [Abstract][Full Text] [Related]
22. Diagnosing and treating hemophagocytic lymphohistiocytosis in the tropics: systematic review from the Indian subcontinent.
Rajagopala S; Singh N
Acta Med Acad; 2012; 41(2):161-74. PubMed ID: 23331391
[TBL] [Abstract][Full Text] [Related]
23. Enteric Fever-Associated Hemophagocytic Lymphohistiocytosis: A Systematic Review of Clinical Characteristics and Outcomes.
Meena DS; Kumar A; Kumar D; Bohra GK; Purohit A
Am J Trop Med Hyg; 2024 Jun; 110(6):1217-1222. PubMed ID: 38579699
[TBL] [Abstract][Full Text] [Related]
24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
25. Anakinra versus etoposide-based therapy added to high-dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis.
Lee BJ; Cao Y; Vittayawacharin P; É'Leima G; Rezk S; Reid J; Brem EA; Ciurea SO; Kongtim P
Eur J Haematol; 2023 Sep; 111(3):477-484. PubMed ID: 37385631
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis.
Horne A; von Bahr Greenwood T; Chiang SCC; Meeths M; Björklund C; Ekelund M; Erensjö P; Berg S; Hagelberg S; Bryceson YT; Andersson U; Henter JI
J Rheumatol; 2021 Oct; 48(10):1596-1602. PubMed ID: 33589555
[TBL] [Abstract][Full Text] [Related]
27. Hemoperfusion with CytoSorb to Manage Multiorgan Dysfunction in the Spectrum of Hemophagocytic Lymphohistiocytosis Syndrome in Critically Ill Children.
Bottari G; Murciano M; Merli P; Bracaglia C; Guzzo I; Stoppa F; Pardeo M; Nunziata J; Del Bufalo F; Genuini L; De Benedetti F; Locatelli F; Cecchetti C
Blood Purif; 2022; 51(5):417-424. PubMed ID: 34344006
[TBL] [Abstract][Full Text] [Related]
28. Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults.
Hines MR; von Bahr Greenwood T; Beutel G; Beutel K; Hays JA; Horne A; Janka G; Jordan MB; van Laar JAM; Lachmann G; Lehmberg K; Machowicz R; Miettunen P; La Rosée P; Shakoory B; Zinter MS; Henter JI
Crit Care Med; 2022 May; 50(5):860-872. PubMed ID: 34605776
[TBL] [Abstract][Full Text] [Related]
29. The Performance of Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.
Meena NK; Sinokrot O; Duggal A; Alpat D; Singh ZN; Coviello JM; Li M; Wang X; Mireles-Cabodevila E
J Intensive Care Med; 2020 Dec; 35(12):1476-1482. PubMed ID: 30862243
[TBL] [Abstract][Full Text] [Related]
30. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
Soy M; Atagündüz P; Atagündüz I; Sucak GT
Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
[TBL] [Abstract][Full Text] [Related]
32. Adjustments to pharmacologic therapies for hemophagocytic lymphohistiocytosis while on extracorporeal support.
Weyand AC; Barbaro RP; Walkovich KJ; Frame DG
Pediatr Blood Cancer; 2021 Jun; 68(6):e29007. PubMed ID: 33751818
[TBL] [Abstract][Full Text] [Related]
33. Protocolized versus non-protocolized weaning for reducing the duration of invasive mechanical ventilation in critically ill paediatric patients.
Blackwood B; Murray M; Chisakuta A; Cardwell CR; O'Halloran P
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009082. PubMed ID: 23900725
[TBL] [Abstract][Full Text] [Related]
34. Clinical Profile, Treatment, and Outcome of Patients with Secondary Hemophagocytic Lymphohistiocytosis in Critically Ill Patients: A Prospective Observational Study.
Fazal F; Gupta N; Soneja M; Mitra DK; Satpathy G; Panda SK; Chaturvedi PK; Vikram NK; Pandey RM; Wig N
Indian J Crit Care Med; 2022 May; 26(5):564-567. PubMed ID: 35719456
[TBL] [Abstract][Full Text] [Related]
35. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
36. Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single center experience and factors that influenced patient prognosis.
Oguz MM; Sahin G; Altinel Acoglu E; Polat E; Yucel H; Oztek Celebi FZ; Unsal H; Akcaboy M; Sari E; Senel S
Pediatr Hematol Oncol; 2019 Feb; 36(1):1-16. PubMed ID: 30821552
[TBL] [Abstract][Full Text] [Related]
37. Nutritional support for critically ill children.
Joffe A; Anton N; Lequier L; Vandermeer B; Tjosvold L; Larsen B; Hartling L
Cochrane Database Syst Rev; 2016 May; 2016(5):CD005144. PubMed ID: 27230550
[TBL] [Abstract][Full Text] [Related]
38. [Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
Su Y; Zhou X; Zhang L; Zhang R
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):938-42. PubMed ID: 24495767
[TBL] [Abstract][Full Text] [Related]
39. Assessment of Long-term Psychological Outcomes After Pediatric Intensive Care Unit Admission: A Systematic Review and Meta-analysis.
Ko MSM; Poh PF; Heng KYC; Sultana R; Murphy B; Ng RWL; Lee JH
JAMA Pediatr; 2022 Mar; 176(3):e215767. PubMed ID: 35040918
[TBL] [Abstract][Full Text] [Related]
40. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review.
Hayden A; Park S; Giustini D; Lee AY; Chen LY
Blood Rev; 2016 Nov; 30(6):411-420. PubMed ID: 27238576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
